Notice of Intent to Sole Source - VITROS 5600 chemistry analyzers with its associated reagents, supplies, and associated support
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- DHA-JB-1
- Agency
-
Defense Health Agency
Department of Defense
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HT940626DE012
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Napoli Italy
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency has awarded contract HT940626DE012 on a sole-source basis under a limited sources justification for two Ortho Clinical Diagnostics VITROS 5600 chemistry analyzers with reagents, supplies, and support, with an award date of September 23, 2026. The notice's description does not identify the vendor. The attached J&A summary names CIDICHEM SRL as the exclusive authorized Ortho Clinical Diagnostics distributor and service provider in the region. The Defense Health Agency Contracting Activity, Healthcare Contracting Division Southeast, awarded the contract on behalf of U.S. Naval Hospital Naples. The action is a Firm Fixed Price IDIQ with no set-aside used, under NAICS 325413 and PSC 6515.
The justification rests on one responsible source under RFO 6.103-1(b). The VITROS 5600 dry-slide analyzers are proprietary, operate without a water source, and align with Navy standardization across medical centers. The hospital cannot transition to alternative systems because of infrastructure limitations, completed personnel training on Vitros equipment, and substantial investment costs. Market research from January through February 2026 found no alternative vendors meeting the requirement. A Sources Sought Notice posted June 11, 2026, with responses due June 30, 2026, yielded only BHPE LLC, which failed to provide the required capabilities statement. The contracting activity has no current plans to compete future contracts for this product category, pending the emergence of additional qualified sources.
Scope includes two analyzers, equipment lease maintenance, full risk maintenance on both analyzers, application support services and testing, and annual on-site training. The base period runs September 1, 2026, through August 31, 2027, with four one-year options through August 31, 2031, and a FAR 52.217-8 period from September 1, 2031, through February 28, 2032.
Notice text
Redacted J&A posted in accordance with RFO 6.301
Awarded contract HT940626DE012 to unknown vendor for unknown amount on 2026-09-23.
Files
| File | Type | Posted |
|---|---|---|
| JA IDIQ Redacted version.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6632--Cath Lab GEM 5000 | Veterans Integrated Service Network 6 | No set-aside | |
| Aptio Automation | Defense Health Agency | No set-aside | |
| Notice of Intent to Sole Source - Lease of Automated Peritoneal Dialysis Cyclers | Defense Health Agency | No set-aside | |
| Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. | Medical Command | No set-aside | |
| AN12--NOVOCYTE 3000 PM&R Services Intent to Sole Source | Veterans Integrated Service Network 22 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity